The findings implied that increased CA125, HE4, SII, NLR, PLR, and FAR levels before surgery, as well as decreased PNI levels, are indicative of a greater likelihood of advanced ovarian cancer progression and lymph node metastasis. Here, WFDC2 is linked to metastatic malignant neoplasm in the lymph nodes.